BUSINESS COMBINATION (Tables)


Table 8: SLG Valuation
	Initial Allocation of Assets and Liabilities		Adjustments		Estimated Allocation of Assets and Liabilities as of December 31, 2025
Cash consideration:
Cash consideration	$	2,000,000	$	-	$	2,000,000
Less: cash acquired	(34,983)		-		(34,983)
Cash consideration, net of cash acquired	1,965,017		-		1,965,017
Noncash consideration:
Common stock (1)	254,071		250,071		504,142
Series E Convertible Preferred Stock (2)	255,000		-		255,000
Accounts receivable in Cycurion owing from SLG (3)	10,814,147		-		10,814,147
Noncash consideration	11,323,218		250,071		11,573,289
Total consideration	$	13,288,235	$	250,071	$	13,538,306
Assets acquired:
Accounts receivable	$	3,066,581	$	-	$	3,066,581
Total identified assets acquired	3,066,581		-		3,066,581
Liabilities assumed:
Accounts payable	4,317,052		-		4,317,052
Accrued liabilities	10,650		54,209		64,859
Payroll liability	40,642		-		40,642
Factoring liability	2,176,922		-		2,176,922
Due to related parties	18,000		-		18,000
Loans payable	625,222		-		625,222
Liabilities to Cycurion	2,982,908		-		2,982,908
Total identified liabilities assumed	10,171,396		54,209		10,225,605
Net identifiable liabilities assumed	(7,104,815)		(54,209)		(7,159,024)
Elimination of inter-company balances	2,982,908		-		2,982,908
Non-controlling interest	(3,464,218)		-		(3,464,218)
Goodwill	13,945,924		304,280		14,250,204
Net assets acquired	$	13,288,235	$	250,071	$	13,538,306

(1)Represents the fair value of 33,609 common stock issued in the SLG transaction based on the quoted stock price on the date of issuance.

(2)Represents the fair value of the Series E Convertible Preferred Stock as is converted to common stock based on the quoted price common stock on the date of issuance.

(3)Represents the fair value of the accounts receivable in Cycurion owing from SLG.

(4)Fair value of the noncontrolling interest based on NCI’s 49% interest in the net assets acquired.

(5)Goodwill is calculated as Total Consideration paid less the net assets acquired.